» Authors » Maria Giuseppina Silletta

Maria Giuseppina Silletta

Explore the profile of Maria Giuseppina Silletta including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 281
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Roncaglioni M, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, et al.
N Engl J Med . 2013 May; 368(19):1800-8. PMID: 23656645
Background: Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients with a previous myocardial infarction or heart failure. We evaluated the potential benefit of such therapy...
2.
Silletta M, Scarano M, Pioggiarella R, DIngianna A, Giugliano R, Ruo M, et al.
Assist Inferm Ric . 2012 Feb; 30(4):198-207. PMID: 22322435
Lifestyle, health and cardiovascular risk: the results of the study "Rischio & Prevenzione". The substantial agreement of the recommendations aimed to promote the so called "healthy lifestyle habits" dose not...
3.
Levantesi G, Marfisi R, Franzosi M, Maggioni A, Nicolosi G, Schweiger C, et al.
Int J Cardiol . 2012 Jan; 167(1):262-9. PMID: 22261690
Background: To date uric acid (UA) is not considered a cardiovascular risk factor, although evidence about a relationship between UA and cardiovascular diseases has been reported. Methods: Information from 10,840...
4.
Levantesi G, Silletta M, Marchioli R
J Multidiscip Healthc . 2011 Jan; 3:79-96. PMID: 21197357
Much evidence on the favorable effects of omega-3 ethyl esters on cardiovascular morbidity and mortality has been obtained in studies performed in healthy subjects and in different clinical settings. Here...
5.
Marchioli R, Silletta M, Levantesi G, Pioggiarella R
Curr Atheroscler Rep . 2009 Oct; 11(6):440-7. PMID: 19852885
During the past three decades, the protective role of omega (n)-3 polyunsaturated fatty acids (PUFA), mainly eicosapentaenoic acid and docosahexaenoic acid, in patients with coronary heart disease has been widely...
6.
Silletta M, Marchioli R
Recenti Prog Med . 2009 Feb; 99(11):533-7. PMID: 19209536
Many epidemiological studies have addressed the effects of coffee on cardiovascular disease. Most case-control studies suggest an increased risk in high coffee consumers, whereas cohort studies indicate no clear association...
7.
Silletta M, Marfisi R, Levantesi G, Boccanelli A, Chieffo C, Franzosi M, et al.
Circulation . 2007 Dec; 116(25):2944-51. PMID: 18056527
Background: The relation between coffee consumption and cardiovascular disease has been studied extensively, but results are still debated. In addition, little evidence is available on patients with established coronary heart...
8.
Levantesi G, Scarano M, Marfisi R, Borrelli G, Rutjes A, Silletta M, et al.
Am J Cardiol . 2007 Nov; 100(11):1644-50. PMID: 18036362
Despite significant progress in the prevention and treatment of cardiovascular disease, sudden cardiac death (SCD) is a major public health problem. Statins showed consistent benefits on cardiovascular events, but scant...
9.
Marchioli R, Marfisi R, Borrelli G, Chieffo C, Franzosi M, Levantesi G, et al.
J Cardiovasc Med (Hagerstown) . 2007 Oct; 8 Suppl 1:S34-7. PMID: 17876196
The GISSI-Prevenzione trial established the efficacy of n-3 polyunsaturated fatty acids (PUFAs) for reducing mortality in patients after recent myocardial infarction. The generalisability of such results to clinical practice could...
10.
Mironov A, Colanzi A, Polishchuk R, Beznoussenko G, Mironov Jr A, Fusella A, et al.
Eur J Cell Biol . 2004 Oct; 83(6):263-79. PMID: 15511084
Dicumarol (3,3'-methylenebis[4-hydroxycoumarin]) is an inhibitor of brefeldin-A-dependent ADP-ribosylation that antagonises brefeldin-A-dependent Golgi tubulation and redistribution to the endoplasmic reticulum. We have investigated whether dicumarol can directly affect the morphology of...